Header cover image

Taiwanese (TAIEX) Drug Retail Industry Analysis

UpdatedFeb 16, 2025
DataAggregated Company Financials
Companies5
  • 7D1.9%
  • 3M-6.1%
  • 1Y-36.0%
  • YTDn/a

The Drug Retail industry is up 1.9% in the last week, with Great Tree Pharmacy up 3.8%. Meanwhile, MARX Biotech actually underperformed within the industry, shrinking 5.7% in the last week. In contrast, the industry has lost 36% in the last 12 months.

Industry Valuation and Performance

Has the Taiwanese Drug Retail Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 16 Feb 2025NT$34.8bNT$31.8bNT$755.8m41.4x46x1.1x
Tue, 14 Jan 2025NT$32.4bNT$31.8bNT$755.8m43.3x42.9x1x
Thu, 12 Dec 2024NT$35.1bNT$31.8bNT$755.8m45.9x46.5x1.1x
Sat, 09 Nov 2024NT$38.8bNT$31.4bNT$774.1m112.6x50.1x1.2x
Mon, 07 Oct 2024NT$41.9bNT$31.0bNT$840.8m113.6x49.8x1.4x
Wed, 04 Sep 2024NT$40.8bNT$31.0bNT$840.8m112.1x48.5x1.3x
Fri, 02 Aug 2024NT$44.1bNT$30.7bNT$873.1m81.1x50.5x1.4x
Sun, 30 Jun 2024NT$44.7bNT$30.7bNT$873.1m80.2x51.2x1.5x
Tue, 28 May 2024NT$48.4bNT$30.7bNT$873.1m83.1x55.4x1.6x
Thu, 25 Apr 2024NT$48.7bNT$30.3bNT$935.7m58.5x52x1.6x
Sat, 23 Mar 2024NT$53.1bNT$30.2bNT$941.1m57x56.5x1.8x
Mon, 19 Feb 2024NT$53.0bNT$29.9bNT$964.0m60.1x55x1.8x
Wed, 17 Jan 2024NT$52.8bNT$26.8bNT$949.0m58.3x55.6x2x
Fri, 15 Dec 2023NT$52.4bNT$26.8bNT$949.0m57.5x55.2x2x
Sun, 12 Nov 2023NT$53.1bNT$26.3bNT$1.0b45.5x52x2x
Tue, 10 Oct 2023NT$57.7bNT$26.3bNT$1.0b48.1x56.5x2.2x
Thu, 07 Sep 2023NT$54.3bNT$26.3bNT$1.0b47x53.2x2.1x
Sat, 05 Aug 2023NT$52.3bNT$26.7bNT$1.3b24.7x41.5x2x
Mon, 03 Jul 2023NT$52.5bNT$26.8bNT$1.3b29.4x41.6x2x
Wed, 31 May 2023NT$49.6bNT$26.6bNT$1.3b23.3x39x1.9x
Fri, 28 Apr 2023NT$52.7bNT$26.0bNT$1.2b24x42.7x2x
Sun, 26 Mar 2023NT$46.6bNT$25.8bNT$1.2b17.9x38.2x1.8x
Tue, 21 Feb 2023NT$41.0bNT$25.1bNT$1.2b15.6x35.2x1.6x
Thu, 19 Jan 2023NT$38.1bNT$25.1bNT$1.2b15.4x32.7x1.5x
Sat, 17 Dec 2022NT$35.2bNT$25.1bNT$1.2b16x30.2x1.4x
Mon, 14 Nov 2022NT$33.2bNT$25.1bNT$1.2b14.6x28.5x1.3x
Wed, 12 Oct 2022NT$31.9bNT$24.3bNT$1.1b19.9x30.3x1.3x
Fri, 09 Sep 2022NT$34.4bNT$24.3bNT$1.1b21.2x32.7x1.4x
Sun, 07 Aug 2022NT$28.5bNT$22.5bNT$789.4m33.2x36x1.3x
Tue, 05 Jul 2022NT$25.7bNT$22.5bNT$789.4m34x32.5x1.1x
Thu, 02 Jun 2022NT$33.2bNT$22.5bNT$789.4m35.6x42x1.5x
Sat, 30 Apr 2022NT$32.5bNT$21.6bNT$739.6m45.6x43.9x1.5x
Mon, 28 Mar 2022NT$32.0bNT$21.7bNT$740.2m35.1x43.2x1.5x
Wed, 23 Feb 2022NT$23.9bNT$20.9bNT$698.1m31.2x34.3x1.1x
Price to Earnings Ratio

34.3x


Total Market Cap: NT$23.9bTotal Earnings: NT$698.1mTotal Revenue: NT$20.9bTotal Market Cap vs Earnings and Revenue0%0%0%
Taiwanese Drug Retail Industry Price to Earnings3Y Average 44.4x202320242025
Current Industry PE
  • Investors are relatively neutral on the Taiwanese Drug Retail industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PE ratio of 44.4x.
  • The 3-year average PS ratio of 1.6x is higher than the industry's current PS ratio of 1.1x.
Past Earnings Growth
  • The earnings for companies in the Drug Retail industry have grown 2.7% per year over the last three years.
  • Revenues for these companies have grown 15% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Comparison

How does Taiwanese Drug Retail compare with similar industries?

TW Market-1.29%
Consumer Staples1.73%
Food and Staples Retail1.74%
Drug Retail1.94%
Food Distributors2.09%
Food Retail1.71%
Big Box Super Stores0%0
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
6469 Great Tree PharmacyNT$162.503.8%
+NT$791.3m
-37.7%PE31.3x
6929 We Can MedicinesNT$41.709.2%
+NT$157.0m
-57.9%PS0.6x
4175 MedFirst Healthcare ServicesNT$67.401.5%
+NT$42.3m
-20.1%PE124.7x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

7731

NT$7.07

MARX Biotech

7D

-5.7%

1Y

-7.6%

6469

NT$162.50

Great Tree Pharmacy

7D

3.8%

1Y

-37.7%

4175

NT$67.40

MedFirst Healthcare Services

7D

1.5%

1Y

-20.1%

6844

NT$135.00

Norbel Baby

7D

-2.2%

1Y

-37.8%

6929

NT$41.70

We Can Medicines

7D

9.2%

1Y

-57.9%